Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Testosterone (TSX-002) Dose Response and Food Effect Study in Hypogonadism
NCT01717768Phase 2Completed
- Sponsor
- TesoRx Pharma
- Start
- Oct 2012
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of testosterone in Hypogonadism, sponsored by TesoRx Pharma. Started Oct 2012; status: completed.
02
Drugs
testosterone
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT01717768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01717768.